We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+11.96%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.1B
AUM Growth
+$1.16B
Cap. Flow
-$151M
Cap. Flow %
-1.49%
Top 10 Hldgs %
46.75%
Holding
616
New
9
Increased
46
Reduced
197
Closed
62

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.4M
2
PAYC icon
Paycom
PAYC
+$10.8M
3
VEEV icon
Veeva Systems
VEEV
+$9.74M
4
PH icon
Parker-Hannifin
PH
+$4.8M
5
WEX icon
WEX
WEX
+$4.15M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$50.9M
2
MA icon
Mastercard
MA
+$21.1M
3
EW icon
Edwards Lifesciences
EW
+$19.4M
4
MSFT icon
Microsoft
MSFT
+$12.3M
5
AAPL icon
Apple
AAPL
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 39.56%
2 Healthcare 17.19%
3 Financials 10.67%
4 Consumer Discretionary 10.19%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTN icon
376
Vail Resorts
MTN
$5.2B
$71.3K ﹤0.01%
321
– –
FE icon
377
FirstEnergy
FE
$27.3B
$70.8K ﹤0.01%
1,931
– –
TIP icon
378
iShares TIPS Bond ETF
TIP
$14.8B
$70.8K ﹤0.01%
656
– –
SLF icon
379
Sun Life Financial
SLF
$44.6B
$67.4K ﹤0.01%
1,300
– –
EPD icon
380
Enterprise Products Partners
EPD
$82.1B
$66.9K ﹤0.01%
2,500
– –
CRSP icon
381
CRISPR Therapeutics
CRSP
$5.19B
$65.2K ﹤0.01%
1,035
– –
SJM icon
382
J.M. Smucker
SJM
$12.9B
$64.9K ﹤0.01%
493
– –
PRU icon
383
Prudential Financial
PRU
$42.6B
$63K ﹤0.01%
600
– –
HUM icon
384
Humana
HUM
$46.1B
$62.4K ﹤0.01%
165
+50
+43% +$24.6K
LNC icon
385
Lincoln National
LNC
$8.51B
$61.8K ﹤0.01%
2,253
– –
T icon
386
AT&T
T
$166B
$61.8K ﹤0.01%
3,495
-900
-20% -$14.2K
BNY
387
Bank of New York Mellon
BNY
$110B
$61K ﹤0.01%
1,100
– –
TNL icon
388
Travel + Leisure Co
TNL
$4.57B
$60.6K ﹤0.01%
1,500
– –
AVAV icon
389
AeroVironment
AVAV
$9.64B
$60.3K ﹤0.01%
500
– –
SWKS icon
390
Skyworks Solutions
SWKS
$10.5B
$59.4K ﹤0.01%
569
– –
SRE icon
391
Sempra
SRE
$56.5B
$57.2K ﹤0.01%
800
– –
SEIC icon
392
SEI Investments
SEIC
$12.7B
$56.9K ﹤0.01%
900
– –
LH icon
393
Labcorp
LH
$26.2B
$55.6K ﹤0.01%
250
– –
CATC
394
DELISTED
CAMBRIDGE BANCORP
CATC
$55.2K ﹤0.01%
805
– –
LBRDK icon
395
Liberty Broadband Class C
LBRDK
$5.15B
$53.8K ﹤0.01%
686
– –
MTRN icon
396
Materion
MTRN
$5.95B
$53.5K ﹤0.01%
457
– –
ATR icon
397
AptarGroup
ATR
$8.42B
$52K ﹤0.01%
400
– –
NEM icon
398
Newmont
NEM
$122B
$51.2K ﹤0.01%
1,485
– –
VTRS icon
399
Viatris
VTRS
$18.7B
$49.9K ﹤0.01%
4,243
– –
MRNA icon
400
Moderna
MRNA
$25.9B
$49.5K ﹤0.01%
490
-120
-20% -$10.1K
14 15
16
17 18

Similar funds

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 616 positions worth $10.1B, up 13% from $8.93B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2023 filing shows 9 new, 46 increased, 197 reduced and 62 closed positions. Its largest new stake was Keurig Dr Pepper: 6,000 shares worth $189K. The largest sale was Danaher, an estimated $50.9M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2023 buy was Keurig Dr Pepper: 6,000 shares worth $189K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q4 2023, an estimated $14.4M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2023 reduction was Danaher, cutting an estimated $50.9M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Amcor in Q4 2023, selling an estimated $1.02M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 47% of its $10.1B portfolio in Q4 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 9 new positions and closed 62 in Q4 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 13% quarter-over-quarter to $10.1B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.